Hair Loss

 

Hair loss (alopecia) can be, but is not always, a side effect of certain chemotherapy drugs. Your health care team will tell you before you start treatment whether you can expect to lose your hair. Hair loss typically begins 2 or 3 weeks after chemotherapy treatment starts.

You may experience thinning or loss of hair on your head, underarms, and leg, and the loss or reduction of your eyebrows, eyelashes, facial hair, and pubic hair. The amount of hair you lose is related to the type of chemotherapy you receive. The good news is that your hair will grow back—typically 1 to 2 months after chemotherapy ends. It may take 6 months or more for your hair to fully grow back.

It can be difficult to prepare yourself for the loss of your hair. This change in your self-image is often a visual reminder to you and others that you are undergoing treatment for cancer. It’s OK to allow yourself to grieve the loss of your hair. Encourage family members, especially children, to express their thoughts and emotions about your hair loss. Remember, losing your hair does not change who you are as a person. You are still you.

Tips for Dealing with Hair Loss

  • Get a short haircut before you begin treatment. It may help you adjust to and manage the loss.
  • Shop for a wig before your hair is gone, especially if you wish to match your natural color. (Be sure to ask your insurance company if it covers the cost of a wig.)
  • Be gentle with your hair. Use mild shampoos and soft hair brushes. Avoid chemicals, including bleach, peroxide, or hair dye.
  • Remember to cover your head or use sunscreen (with an SPF of at least 15) on your scalp. Your skin may be particularly sensitive to ultraviolet (UV) rays.
  • Shaving your head before your hair starts to fall out can give you a sense of control over your situation.
  • Besides wigs, try hats, scarves, and turbans. You may prefer these to a wig. Or you may decide not to cover your head at all. It’s up to you.
  • There are programs that teach makeup and accessorizing techniques to cancer patients. Ask your health care team for information.
This content was last modified on August 29, 2007 .
Latest Cancer News
Radiofrequency Ablation Effective For Small Renal Cell Carcinoma and Other Masses

March 11, 2010 — Researchers from the M. D. Anderson Cancer Center have reported that radiofrequency ablation (RFA) is effective treatment for patients with renal masses, including renal cell carcinoma (RCC). The details of this study were presented at the 2010 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium March 5-7 in San Francisco.

Single-dose Neulasta® as Effective as Multiple-dose Neupogen® in Children with Sarcoma

March 11, 2010 — Researchers involved in an international multicenter randomized trial have reported that single-dose Neulasta® (pegfilgrastim) is as effective as multiple-dose Neupogen® (filagrastim) for support of children receiving intensive chemotherapy for previously treated sarcoma. The details of this study were published in the March 10, 2010 issue of the Journal of Clinical Oncology.

Updated Survival Data on Provenge® for Treatment of Hormone Refractory Prostate Cancer Presented

March 11, 2010 — Researchers affiliated with the IMPACT trial have reported that additional follow-up and more analyses demonstrate a clear survival advantage of Provenge® (sipuleucel-T) versus placebo in men with hormone-refractory prostate cancer. The details of this study were presented at the 2010 Genitourinary Cancers Symposium in San Francisco between March 5 and 7.

Select news items provided by Reuters Health